Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02325557
Title ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Patients With Prostate Cancer - KEYNOTE-046
Recruitment Unknown status
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Advaxis, Inc.
Indications

prostate cancer

Therapies

Pembrolizumab

ADXS31-142

Age Groups: adult
Covered Countries USA


No variant requirements are available.